BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu DS, Hoefnagel SJ, Fisher OM, Krishnadath KK, Montgomery KG, Busuttil RA, Colebatch AJ, Read M, Duong CP, Phillips WA, Clemons NJ. Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis. Oncotarget 2016;7:83342-58. [PMID: 27863424 DOI: 10.18632/oncotarget.13391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Hoppe S, Meder L, Gebauer F, Ullrich RT, Zander T, Hillmer AM, Buettner R, Plum P, Puppe J, Malter W, Quaas A. Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus. Cancers (Basel) 2022;14:4789. [PMID: 36230712 DOI: 10.3390/cancers14194789] [Reference Citation Analysis]
2 Fujihara KM, Zhang BZ, Jackson TD, Ogunkola MO, Nijagal B, Milne JV, Sallman DA, Ang C, Nikolic I, Kearney CJ, Hogg SJ, Cabalag CS, Sutton VR, Watt S, Fujihara AT, Trapani JA, Simpson KJ, Stojanovski D, Leimkühler S, Haupt S, Phillips WA, Clemons NJ. Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Sci Adv 2022;8:eabm9427. [DOI: 10.1126/sciadv.abm9427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tratnjek L, Sibinovska N, Kralj S, Makovec D, Kristan K, Kreft ME. Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testing. Sci Rep 2021;11:6664. [PMID: 33758229 DOI: 10.1038/s41598-021-85530-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao P, Liu H, Yang Z, Hui Y, Shi Z, Yang Z, Song M, Yao M, Fan W, Yang J, Hao Y, Fan T. Development of a Novel Highly Spontaneous Metastatic Model of Esophageal Squamous Cell Carcinoma Using Renal Capsule Technology. Onco Targets Ther 2021;14:785-93. [PMID: 33574674 DOI: 10.2147/OTT.S290564] [Reference Citation Analysis]
5 Fujihara KM, Zhang B, Jackson TD, Nijiagel B, Ang C, Nikolic I, Sutton V, Trapani J, Simpson KJ, Stojanovski D, Leimuehler S, Haupt S, Phillips WA, Clemons NJ. Genome-wide CRISPR screens reveal APR-246 (Eprenetapopt) triggers ferroptosis and inhibits iron-sulfur cluster biogenesis.. [DOI: 10.1101/2020.11.29.398867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kashima H, Noma K, Ohara T, Kato T, Katsura Y, Komoto S, Sato H, Katsube R, Ninomiya T, Tazawa H, Shirakawa Y, Fujiwara T. Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma. Int J Cancer 2019;144:828-40. [PMID: 30367467 DOI: 10.1002/ijc.31953] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 8.4] [Reference Citation Analysis]
7 Tao H, Chen YY, Sun ZW, Chen HL, Chen M. Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90. J Cell Biochem. 2018;119:6623-6632. [PMID: 29665050 DOI: 10.1002/jcb.26841] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
8 Hassan MS, von Holzen U. Animal Model: Xenograft Mouse Models in Esophageal Adenocarcinoma. Methods Mol Biol 2018;1756:151-64. [PMID: 29600368 DOI: 10.1007/978-1-4939-7734-5_14] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Derouet MF, Dakpo E, Wu L, Zehong G, Conner J, Keshavjee S, de Perrot M, Waddell T, Elimova E, Yeung J, Darling GE. miR-145 expression enhances integrin expression in SK-GT-4 cell line by down-regulating c-Myc expression. Oncotarget 2018;9:15198-207. [PMID: 29632636 DOI: 10.18632/oncotarget.24613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
10 Christou N, Perraud A, Blondy S, Jauberteau MO, Battu S, Mathonnet M. E-cadherin: A potential biomarker of colorectal cancer prognosis. Oncol Lett. 2017;13:4571-4576. [PMID: 28588719 DOI: 10.3892/ol.2017.6063] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]